Instructions to authors:
Cancer Therapy
OPEN ACCESS www.cancer-therapy.org
ISSN print: 1543-9135; ISSN on-line: 1543-9143

Scope

This journal, bridging various fields is one of the most rapid with free access at
www.cancer-therapy.org.

The scope of Cancer Therapy is to rapidly publish original and in-depth review articles on cancer embracing all fields from molecular mechanisms to results on clinical trials. Articles (both invited and submitted) review or report novel findings of importance to a general audience in cancer therapy, molecular medicine, gene discovery, and molecular biology with emphasis to molecular mechanisms and clinical applications. The journal will accept papers on all aspects of cancer, at the clinical, preclinical or cell culture stage on chemotherapy and new experimental drugs, gene discovery, cancer immunotherapy, DNA vaccines, use of DNA regulatory elements in gene transfer, cell therapy and drug discovery related to cancer therapy. The authors are encouraged to elaborate on the molecular mechanisms that govern a cancer therapy approach. To make the publication attractive, authors are encouraged to include color figures.

Type of articles

Both review articles and original research articles will be considered. Original research articles should contain a generous introduction in addition to experimental data. The articles contain information important to a general audience as the volume is addressed also to researches outside the field. There is no limit on the length of the articles provided that the subject is interesting to a general audience and covers exhaustively a field. The typical length of each manuscript is 12-60 manuscript pages (approximately 4-20 printed pages) plus Figures and Tables.

Free of Charge publication, Complimentary reprints & Subscriptions

There are no page charges, no fees for color reproduction, and furthermore, authors receive 25 free reprints, a hard-bound issue containing their article, and an electronic format of their article that they can use in their personal website or to distribute freely to colleagues. Authors are also entitled to use Figures from their work originally published in Cancer Therapy in review articles for other journals by simply citing the original source.

Sections of the manuscript

Each manuscript should have a Title, Authors, Affiliation, Corresponding Author (with Tel, Fax, and E-mail), Summary, and Introduction; review articles are subdivided into headings I, II, III, etc. (starting with I. Introduction) and subdivided into A, B, C, etc. You can further subdivide into 1, 2, 3, etc. Research articles are divided into Summary; I. Introduction; II. Materials and Methods; III. Results IV Discussion, Acknowledgments and References. Please include in your text citations the name of authors and year in parenthesis; for three or more authors use: (name of first author et al, with year); for two authors please use both names. Please delete hidden text for references. In the reference list, please, type references with year and Journal in boldface and provide full title of the
article such as:

Buschle M, Schmidt W, Berger M, Schaffner G, Kurzbauer R, Killisch I, Tiedemann J-K, Trska B, Kirlappos H, Mechtler K, Schilcher F, Gabler C, and Birnstiel ML (1998) Chemically defined, cell-free cancer vaccines: use of tumor antigen-derived peptides or polyepitope proteins for vaccination. Gene Ther Mol Biol 1, 309-321.

Please use Microsoft Word, font "Times" (Mac users) or "Times New Roman" (PC users) and insert Greek or other characters using the "Insert/Symbol" function in the Microsoft Word rather than simple conversion to font "Symbol". Please boldface Figure 1, 2, 3 etc. as well as Table 1, 2, etc. throughout the text. Please provide the highest quality of prints of your Figures; whenever possible, please provide in addition an electronic version of your figures (optional).

Corresponding authors are kindly requested to provide a color (or black/white) head photo (preferably 4x5 cm or any size), or a group photo of the authors, as we shall include these in the publication.

Submission and reviewing

Peer reviewing is by members of the Editorial Board and external referees. Please suggest 2-3 reviewers providing their electronic addresses, mailing addresses and telephone/fax numbers. Authors are being sent page proofs. Cancer Therapy (Volume 1, 2003) is published on high quality paper with excellent reproduction of color figures and electronically.


Reviewing is completed within 2-3 weeks from receiving the manuscript. Articles accepted without revisions (i.e., review articles) will be published online (www.cancer-therapy.org) in approximately 1 month following submission. Please submit an electronic version of full text and figures preferably in jpeg format. The electronic version of the figures will be used for the rapid reviewing process. High quality prints or photograph of the figures and the original with one copy should be sent via express mail to the Editorial Office.


Editorial Office

Gene Therapy& Molecular Biology
Cancer Therapy

Teni Boulikas, Ph.D.
Gregoriou Afxentiou 7
Alimos, Athens 17455
Greece
Tel: +30-210-985-8454
Fax: +30-210-985-8453

And electronically to:
Maria Koutoudi, B.A. , M.A.
Editor Assistant
Afxentiou 7
Alimos, Athens 17455
Greece
Tel: +30-210-9858-454
Fax: +30-210-9858-453
Email: maria.koutoudi@cancer-therapy.org

The open electronic access to articles published in "Cancer Therapy" to a big general audience, the attractive journal title, the speed of the reviewing process, the no-charges for page numbers or color figure reproduction, the 25 complimentary reprints, the rapid electronic publication, the embracing of many fields in cancer, the anticipated high quality in depth reviews and first rate research articles and most important, the eminent members of the Editorial Board assembled are prognostic factors of a big success for the newly established journal

Citation in MedLine
If you have NIH funded research program your full article published in Gene Therapy & Molecular Biology or Cancer Therapy will appear on PubMed as full article freely accessible.
Articles accepted for publication by Cancer Therapy can be included in MedLine (PubMed) as full articles upon the request of authors provided that the authors have completed their published work under a government grant by NIH (or EU/Japan government grant). If this is your case, please consult the NIH Manuscript Submission System http://www.nihms.nih.gov/.

Cancer Therapy and Gene Therapy & Molecular Biology are Abstracted & Indexed in:
Chemical Abstracts
Directory of Open Access Journals (DOAJ)
Open J-Gate
HEAL-Link
Genamics
ExLibris
EBSCO Host
British Library Direct
Hinari Access to Research Initiative
PubMed Central (under consideration)

Gene Therapy & Molecular Biology that is included in Gene Therapy Net is also Abstracted & Indexed in:
Thompson Scientific
Scopus

Furthermore, they are listed and electronically searchable in many libraries, institutes and universities worldwide, such as Karolinska Institute, Max Planck Institute, Geneva Foundation for Medical Education and Research, National Research Council of Canada, San Jose Public Libraries, California Digital Library, German Electronic Journals Library, Memorial University, Stanford University, Columbia University, University of Oslo, Kun Shan University (Taiwan), Charles Sturt University (Australia), OhioLink Library, Berkley Library and many more.

Cancer Therapy is acknowledged by the National Library of Medicine
http://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed
search field: Cancer Ther
search: journals
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=nlmcatalog&doptcmdl=Expanded&cmd=search&Term=101174596[NlmId]